StockWatch
·

LINCOLN PHARMACEUTICALS LTD. Q4 FY26 Results

LINCOLNQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue187.2812.6%11.3%
Total Income183.080.9%13.5%
Expenditure166.3813.4%14.7%
PBT16.7051.9%2.8%
Net Profit11.6359.3%0.5%
OPM13.27%0.92pp2.62pp
NPM6.35%9.41pp0.83pp
EPS5.8159.3%0.5%
View full financials

Informational and educational content only. Not investment advice.